To identify potential industry partners in Africa that can enhance supply resilience and access to medicines by strengthening regional manufacturing and the broader supply ecosystem.

WHO
To identify potential industry partners in Africa that can enhance supply resilience and access to medicines by strengthening regional manufacturing and the broader supply ecosystem. Request for EOI

Reference: RFI 2024.01
Beneficiary countries or territories: Switzerland
Published on: 09-Jul-2024
Deadline on: 15-Aug-2024 17:00 (GMT 2.00)

Description

The Africa Centers for Disease Control and Prevention (Africa CDC), Unitaid and other partners are collaborating to strengthen regional manufacturing of therapeutics for maternal health, malaria, and HIV in Africa. This Call for Expressions of Interest (EOI) aims to identify potential industry partners in Africa that can enhance supply resilience and access to these medicines by strengthening regional manufacturing and the broader supply ecosystem.

Target Products: Unitaid’s potential support in this first wave of interventions will be designed to be complementary to existing Unitaid-funded projects

  • Medicines for Prevention and Treatment of Post-Partum Hemorrhage (PPH)
  • New Malaria Treatments, including non-artemisinin-based drugs
  • Therapeutics for HIV and related Co-infections

Scope of the EOI: Expressions of Interest should be clearly marked in one or more categories as listed below:

  • Category 1: Active Pharmaceutical Ingredient and/or Finished product manufacturing for Africa-based manufacturers.
  • Category 2: Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) based outside of LMICs willing to work with or transfer technology to manufacturers based in LMICs.
  • Category 3: Generic manufacturers, CDMOs, CMOs or industry partners seeking partnerships or technology transfer to strengthen the regional manufacturing ecosystem.
  • Category 4: Contract Research Organizations and Quality Testing Organizations based in LMICs.

Out of Scope:

  • Upstream new product development
  • Interventions targeting traditional medicines
  • Interventions/projects focused only on product delivery or program implementation
  • Regional manufacturing of oxygen and oxygen-related products
  • Diagnostics

Applicant Profile: This EOI targets manufacturers and related service providers with an interest (commercial or non-commercial) in strengthening regional manufacturing in Africa.

  • Committed to manufacturing quality-assured, affordable priority health products
  • Committed to strengthening local and regional supply in Africa

Instructions to Interested Parties:

  • Submit EOIs in English by August 15, 2024.
  • Include a brief business overview focused on capabilities, products, and experience.
  • Submit EOIs here. (https://tinyurl.com/28b4b9ex)
  • Questions can be sent to Unitaid-proc@who.int by July 30, 2024.

Additional Information:

  • Costs of preparing documents are borne by the applicant.

  • Submissions and supporting documents are considered confidential.

This EOI will inform Unitaid's future investments and efforts to accelerate and strengthen regional manufacturing in Africa. It may result in future funding opportunities through targeted Requests for Proposals (RFPs).

For detailed information and the complete EOI response format, please refer to the attached RFI (request for information).